Skip to content

Age Stereotype Priming and Social Participation

Age Stereotype Priming and Moderating Effects of Social Participation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04202120
Acronym
ASPSP
Enrollment
150
Registered
2019-12-17
Start date
2018-01-12
Completion date
2020-12-31
Last updated
2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging Well, Memory Loss

Keywords

Age stereotypes, episodic memory, social participation

Brief summary

Memory performance is shown to be affected by age stereotypes among older adults. The purpose of the study is to examine the effects of age stereotype primes on episodic memory using priming intervention. The moderating effects of social participation is also examined.

Detailed description

All participants are community-dwelling older adults residing in Hong Kong. They are invited to review their social participation profile and given a brief psycho-education about memory. They are then randomly allocated to one of the two following conditions. Participants are primed either with age stereotypes or non-age stereotypes words by implicit priming intervention in the context of a reaction task prior to the episodic memory tasks. Other measures such as demographic variables and social participation rate are collected by questionnaire during the delayed recall interval.

Interventions

OTHERAge-related stereotyping priming

The priming intervention was performed using the E-prime 2.0 software (Psychology Software Tools, Pittsburgh, PA). To ensure the primes flashed on screen were beyond awareness, the similar adjustment procedure was taken (see Levy, 1996; Stein et al., 2002). After the trial block, participants were asked to try to report any words viewed during each trial. The stimulus onset asynchrony (SOA) will be reduced or enhanced whenever 2 words or above were correctly reported or no single word could be reported respectively. The priming SOA for this study ranged from 32 ms to 208 ms (M = 98.70 ms. SD = 48.60).

OTHERNon age-related stereotype priming

he priming intervention was performed using the E-prime 2.0 software (Psychology Software Tools, Pittsburgh, PA). To ensure the primes flashed on screen were beyond awareness, the similar adjustment procedure was taken (see Levy, 1996; Stein et al., 2002). After the trial block, participants were asked to try to report any words viewed during each trial. The stimulus onset asynchrony (SOA) will be reduced or enhanced whenever 2 words or above were correctly reported or no single word could be reported respectively. The priming SOA for this study ranged from 32 ms to 208 ms (M = 98.70 ms. SD = 48.60).

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
55 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Indication of largely normal cognitive functioning as screened on the Montreal Cognitive Assessment (MoCA) with Hong Kong norms -

Exclusion criteria

Sensory deficits and evidence of cognitive impairment as screened on the Montreal Cognitive Assessment (MoCA) with Hong Kong norms \-

Design outcomes

Primary

MeasureTime frameDescription
Hong Kong List Learning TestChange from baseline through study completion, an average of 2 hoursThe Hong Kong List Learning is a validated tool for assessing episodic memory for aged Chinese speaking adults (Chan, 2006). It was further taken for investigating differences among older adults with normal cognitive ability and older adults with mild cognitive impairment (Yeung et al., 2016). The random control list was taken in this study. It comprises 16 words formed by four categories:

Countries

Hong Kong

Contacts

Primary ContactAlma Au, PhD
ssalma@polyu.edu.hk+85293609492
Backup ContactStephen Chan, Masters
sccy.chan@connect.polyu.hk+85227667746

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026